Join our Panic Disorder Study Today
Take part in a new research study for a potential new oral treatment for Panic Disorder.
This study aims to evaluate the safety and effectiveness of a potential new oral treatment for Panic Disorder in adults between 18-65 years of age.
Critical Eligibility Criteria:
To take part in this study, you will need to meet all the following:
- Aged between 18 and 65 years
- Diagnosis of Panic Disorder or struggling with recurring panic attacks
- Willing to comply with contraception requirements
- Willing to remain on current doses of other psychiatric medications throughout the length of the trial
Commitment:
If you are deemed eligible for the study, your participation is expected to last approximately 15 weeks. This includes:
- 6 visits to the study site
- 8 video calls
- 1 phone call
Locations:
Australia - VIC, NSW, SA
If you take part in this research study, there will be:
Reimbursement of costs
For out-of-pocket expenses, such as travel and parking.
Convenience
There are no overnight stays
Free study-related medical care
Be among the first to access potential new research treatments before they are widely available.
Expert medical monitoring
Receive top-tier medical care and monitoring from experienced healthcare professionals.
Contribution to medical research
Help investigate a potential new treatment that could improve the lives of individuals with Panic Disorder
Register your interest now
or scroll down to read the study FAQs
Study Guide
01
Who can take part in this study?
-
To take part, you must meet the following criteria (additional criteria apply):
- Aged between 18-65 years
- Have a diagnosis of Panic Disorder or struggling with recurring panic attacks
- Willing to comply with contraception requirements
- Willing to remain on current doses of other psychiatric medications throughout the length of the trial
02
Who is unable to take part in this study?
+
Unfortunately, if any of the following apply to you, this study is not the right fit for you:
- History of severe agoraphobia
- Currently pregnant or breastfeeding
- Recent participation in a clinical trial (within last 3 months)
- Severe uncontrolled cardiac disease within 6 months of screening
Please note, additional eligibility criteria apply.
03
What does the study involve for participants?
+
If you are deemed eligible for the study, your participation is expected to last approximately 15 weeks, and you will be required to attend the study site up to 6 times. This includes:
- 6 visits to the study site (inclusive of initial screening visit, conversation with study doctor and information review)
- 8 video calls
- 1 phone call
Participation in this research is voluntary, and you may withdraw from the study at any time.
04
What is the purpose of this study?
+
This study will aim to improve symptoms associated with Panic Disorder and will aim to develop a potential new oral treatment option targeting areas where there are not currently available treatments for Panic Disorder. In time, potentially providing an alternative new oral treatment option for Panic Disorder.
05
What is Panic Disorder?
+
Panic Disorder is charaterised by experiencing symptoms like a feeling of discomfort, increased fear or sense of loss of control when there is no clear trigger. Physical symptoms people experience include trembling, rapid heart rate or sweating among many others.
06
Why is this study important?
+
This study will aim to improve symptoms associated with Panic Disorder and will aim to develop a potential treatment option targeting areas where there are not currently available treatments for Panic Disorder. In time, potentially providing an alternative treatment option for Panic Disorder.
07
Who is sponsoring this study?
+
This study is being sponsored by HB Biotech Ltd.
08
Where is my nearest study site?
+
Here is a list of all of the sites who are currently recruiting for this study:
09
What if I have other questions about the study?
+
We are here for you! Head to our Evrima Help Centre and search for answers relating to clinical trials, study information and managing your Evrilink account
This study has been approved by an independent Human Research Ethics Committee
Help make medical research breakthroughs happen.
Need help with clinical trial information?
Search our Evrima help Centre for answers related to information about our active studies, information about managing your Evrilink account, and general clinical trial knowledge!
Read our FAQs